10.11.2015 09:14:00

Stallergenes Greer Appoints Michele Antonelli as Executive Vice President, Head of International Operations

Regulatory News:

Stallergenes Greer plc (Paris:STAGR) has announced the appointment of Michele Antonelli as Executive Vice President, Head of International Operations on 9 November 2015.

Michele has more than 20 years’ extensive international experience in the biopharmaceutical industry. For the past 7 years, Michele has worked at UCB, where he has held roles of various responsibility and scope, most recently holding the position of Executive Vice President and Head of lmmunology Europe, overseeing commercial, medical and market access activities in the region. Michele gained extensive experience in setting up and managing commercial and technical operations in Europe, the United States, Latin America, Israel and Asia. Prior to joining UCB, Michele spent 16 years at Merck Serono, ultimately in the role of Senior Vice President and Global Head of Biotech Manufacturing and Process Development in Geneva.

Christian Chavy, Head of Commercial Operations Europe & ROW of Stallergenes Greer, said: "We are delighted to welcome Michele Antonelli. His leadership experience within successful biopharmaceutical companies, combined with his extensive knowledge of the key markets in which Stallergenes Greer operates, will support our company in its future development and in fully capitalizing on our value creation strategy around the world.

ABOUT STALLERGENES GREER PLC

Headquartered in London (UK), Stallergenes Greer plc is a global company specializing in the diagnosis and treatment of allergies through the development and commercialization of allergy immunotherapy products and services. Stallergenes Greer plc is the parent company of GREER Laboratories, Inc. (whose registered office is in the U.S.) and Stallergenes S.A.S. (whose registered office is in France).

Trading information:
Name: Stallergenes Greer
ISIN: GB00BZ21RF93 1 - Ticker: STAGR
ICB classification: 4577
Market: Euronext Paris regulated market

Additional information is available at http://www.stallergenesgreer.com

Nachrichten zu Ares Allergy Holdings PLCmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Ares Allergy Holdings PLCmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!